MAZZEI, TERESITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.137
EU - Europa 8.569
AS - Asia 1.911
AF - Africa 59
SA - Sud America 33
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.725
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.105
RU - Federazione Russa 3.022
PL - Polonia 1.532
IE - Irlanda 1.102
SE - Svezia 819
IT - Italia 812
SG - Singapore 629
HK - Hong Kong 534
UA - Ucraina 363
DE - Germania 344
CN - Cina 285
FI - Finlandia 262
IN - India 189
GB - Regno Unito 151
JO - Giordania 101
TR - Turchia 95
FR - Francia 45
CI - Costa d'Avorio 42
CA - Canada 32
CH - Svizzera 30
BE - Belgio 26
VN - Vietnam 26
KR - Corea 25
ES - Italia 18
SC - Seychelles 16
NL - Olanda 14
AR - Argentina 13
PE - Perù 11
NZ - Nuova Zelanda 9
BR - Brasile 8
AT - Austria 6
GR - Grecia 5
IR - Iran 5
CZ - Repubblica Ceca 4
TW - Taiwan 4
AU - Australia 3
EU - Europa 3
IQ - Iraq 3
PK - Pakistan 3
PT - Portogallo 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
LT - Lituania 2
MK - Macedonia 2
SA - Arabia Saudita 2
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
EC - Ecuador 1
EE - Estonia 1
ID - Indonesia 1
LK - Sri Lanka 1
MA - Marocco 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
Totale 23.725
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.852
Warsaw 1.531
Chandler 1.148
Dublin 1.099
Fairfield 1.038
Jacksonville 676
Ashburn 554
Singapore 488
Woodbridge 480
Cambridge 464
Seattle 420
Wilmington 374
Houston 373
Hong Kong 269
Princeton 259
Ann Arbor 226
Boston 183
Boardman 177
Mumbai 155
Lawrence 151
Altamura 136
Buffalo 134
Florence 124
Medford 106
Shanghai 90
Beijing 71
San Diego 63
Izmir 54
Milan 52
Norwalk 51
New York 48
Dearborn 46
Moscow 46
Los Angeles 44
Abidjan 42
West Jordan 41
Hillsboro 38
Helsinki 37
Falls Church 36
Bremen 32
Bern 28
Toronto 25
Auburn Hills 22
Guangzhou 22
Pune 22
Yubileyny 22
Brussels 21
Kent 20
Andover 19
Rome 19
Dong Ket 18
Bologna 17
Frankfurt Am Main 16
Redwood City 16
London 13
Barcelona 12
Palermo 11
Bari 10
Catania 10
Redmond 10
Buenos Aires 8
Giugliano in Campania 8
Lima 8
Phoenix 8
Laurel 7
Arezzo 6
Auckland 6
Salerno 6
Trieste 6
Washington 6
Kunming 5
Modena 5
Munro 5
Athens 4
Aversa 4
Cagliari 4
Genoa 4
Lastra a Signa 4
Munich 4
Pavia 4
Pederobba 4
San Mateo 4
Sesto Fiorentino 4
São Paulo 4
Taipei 4
Tappahannock 4
Verona 4
Vienna 4
Baghdad 3
Bangkok 3
Brescia 3
Campo Grande 3
Cassola 3
Castelli Calepio 3
Codevigo 3
Coreno Ausonio 3
Duncan 3
Fuzhou 3
Hanoi 3
Hefei 3
Totale 15.741
Salva come PNG Salva come JPEG
Nome #
Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents. 272
Farmaci antineoplastici - Farmaci inibitori della trasduzione del segnale - Farmaci inibitori di protein chinasi 252
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 245
A survey on infection management practices in Italian ICUs 241
Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012 236
A survey on infection management practices in Italian ICUs. 234
Intraoperative positive fluid balance improves tissue diffusion of ceftizoxime. 231
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic Acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy. 226
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now? 216
How to manage aspergillosis in non-neutropenic intensive care unit patients. 215
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 214
Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors. 180
Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: End of an era? 180
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) 161
Comportamenti sessuali e contraccezione 150
Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu). 145
Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin 142
Cellular pharmacology of gemcitabine. 142
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 141
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 141
MOLECULAR CHARACTERIZATION OF ESTABLISHED HUMAN COLON CARCINOMA CELL LINES (HCT-8) MADE RESISTANT TO 5-FLUOROURACIL BY DIFFERENT SELECTION SCHEDULES 139
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 138
Ertapenem peritoneal fluid concentrations in adult surgical patients. 131
Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation. 126
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 125
Amoxicillin/clavulanic acid versus cefotaxime for antimicrobial prophylaxis in abdominal surgery: a randomized trial. 124
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 121
Azithromycin concentrations in serum and bronchial secretions of patients with cystic fibrosis 120
The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach. 120
Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. 119
Increased levels of CA 125 and CA 19·9 serum tumour markers following cyclic combined hormone replacement therapy 118
Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds. 116
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 116
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 115
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. 115
Gold(III) Complexes with Bipyridyl Ligands: Solution Chemistry, Cytotoxicity and DNA Binding Properties 113
In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin. 112
Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options 111
Induction of differentiation of HL-60 cells along the monocytic pathway by 5-methyltetrahydrofolate. 111
Pharmacokinetic evaluation of meropenem and imipenem in critically-ill patients with sepsis. 111
Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum 110
Pharmacological rationale for antibiotic treatment of intra-abdominal infections. 110
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity 110
Adverse effects of macrolide antibacterials. 108
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations 108
Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections. 107
Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial. 105
Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. 105
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 103
Intra-arterial chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer 103
Gender-related health in tuscany 103
Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients. 102
Efficacy of caspofungin against Aspergillus terreus. 101
Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery. 101
Clinical pharmacokinetics of depot leuprorelin. 101
Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinoma. 101
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides. 100
The difficulties of polytherapy: examples from antimicrobial chemotherapy 100
Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. 99
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM. 99
Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. 98
Pharmacokinetics and blister fluid penetration of brodimoprim in adults. 98
Pharmacokinetics of roxithromycin in renal and hepatic failure and drug interactions. 98
In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin. 97
Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients. 97
Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis 97
Postantibiotic leukocyte enhancement of meropenem against Gram-positive and Gram-negative strains 97
The penetration of intramuscular cefotetan disodium into human extravascular fluid and maternal milk secretion. 97
Description of the disease and diagnostic and epidemiologic aspects 97
Ciprofloxacin inhibition of cefoxitin betalactamase induction in an Enterobacter cloacae strain. 97
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 97
Etiology issues and problems of antibiotic resistance 97
PHASE II TRIAL OF 5-FLUOROURACIL AND THE NATURAL L-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL CARCINOMA. 96
Tissue distribution of cefotetan in patients with Crohn's disease. 96
Dibekacin in vitro activity on recently isolated bacterial strains from various clinical materials. 96
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 95
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma. 95
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 95
Betalactam therapy and intestinal flora. 94
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells. 94
Tissue distribution of antimicrobial drugs. 94
Fluorochinoloni. 94
Farmacologia degli antibiotici nelle infezioni della cute e dei tessuti molli 94
Moxalactam pharmacokinetics in healthy volunteers and patients with renal insufficiency. 93
New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock. 93
Interactions between triazoles and amphotericin B against Cryptococcus neoformans. 93
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 93
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits? 92
Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. 92
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 92
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer. 91
Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate. 91
Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. 91
Therapeutic recommendations of the multidisciplinary group. 91
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance 90
Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients (pts) with metastatic colorectal cancer (MCRC) pretreated with CPT11- or OHP-based CHT 90
Urological infections due to multidrug-resistant bacteria: what we need to know? 90
Pharmacological aspects of the antibiotics used for urological diagnostic procedures 90
Clinical pharmacokinetics of meropenem after the first and tenth intramuscular administration. 89
The pharmacokinetics of oral cephalosporins. 89
Totale 12.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.647
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.647
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.696 0 0 0 0 0 365 274 383 246 154 237 37
2020/20211.985 167 110 197 182 91 285 60 199 148 260 113 173
2021/20221.481 33 212 45 95 45 45 47 110 58 34 315 442
2022/20234.514 404 491 145 426 465 919 618 279 516 27 128 96
2023/20241.648 98 187 346 84 117 235 67 337 21 63 42 51
2024/20258.632 471 1.226 679 1.694 3.212 1.350 0 0 0 0 0 0
Totale 23.927